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Previously isolated mutants of Mycoplasma pneumoniae incapable of hemad-
sorption were characterized with respect to specific protein content, tracheal ring
attachment capability, and virulence for both in vitro and in vivo model systems.
Two-diimensional gel electrophoresis revealed both quantitative and qualitative
differences between the protein complements of two different mutant strains and
that of the virulent parent strain. Studies of mycoplasma attachment to hamster
tracheal rings in vitro demonstrated that only one of these mutant strains still
possessed the ability to attach to the respiratory epithelium via neuraminidase-
sensitive receptors. Measurement of [3H]orotic acid uptake in mycoplasma-in-
fected tracheal rings indicated that infection with the hemadsorption-negative
mutants resulted in only slight reductions of ribonucleic acid synthesis, similar to
levels observed for tracheal rings infected with an avirulent strain of M. pneu-
moniae. The virulence potential ofthe two mutant strains was further investigated
by utilizing the hamster model system. Both mutant strains were rapidly cleared
from the lungs of infected animals and produced little or no microscopic pneu-
monia.
Mycoplasmapneumoniae is a procaryotic res-
piratory tract pathogen that can produce disease
in virtually all segments of the upper and lower
respiratory tract and is best known for its ability
to cause cold agglutinin-associated primary
atypical pneumonia. The mechanisms employed
by this organism in the production of disease are
just beginning to be elucidated (7, 9, 16a). The
ability of this organism to parasitize the respi-
ratory tract is related at least in part to its ability
to adhere to respiratory tract epithelium (9).
The use of hamster tracheal organ culture has
allowed detailed in vitro examination of both
this adherence process (2, 9, 15) and the subse-
quent pathological effects exerted on the respi-
ratory tract epithelium by attached and meta-
bolically active M. pneumoniae cells (2, 7, 8).
The importance of adherence in the production
of M. pneumoniae-associated disease has been
inferred from the fact that a strain of M. pneu-
moniae which has spontaneously lost the ability
to adhere to respiratory tract epithelium is also
no longer capable of causing experimental pneu-
monia in a hamster model system (11, 15). The
relevance of this adherence process to human
respiratory disease has been established by the
observation of attached mycoplasmas on respi-
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ratory tract epithelial cells obtained from pa-
tients infected with M. pneumoniae (3).
In addition to the property of surface attach-
ment, virulent strains of M. pneumoniae also
form colonies which adsorb erythrocytes in a
process called hemadsorption (12). Hemadsorp-
tion bears certain similarities to respiratory ep-
ithelium attachment by M. pneumoniae in that
(i) many of the receptor sites forM. pneumoniae
on both erythrocytes of certain animal species
and respiratory epithelial cells appear to contain
sialic acid residues (16), and (ii) trypsin treat-
ment of colonies of virulent M. pneumoniae
eliminates their ability to adsorb either eryth-
rocytes or respiratory epithelial cells (16). These
data, which suggested that M. pneumoniae
might employ the same mechanism(s) for at-
tachment to both respiratory epithelium and
erythrocytes, prompted us to isolate mutants of
M. pneumoniae deficient in hemadsorption (5).
Such mutants could be used both to further
evaluate the relationship between hemadsorp-
tion and respiratory epithelium attachment abil-
ity in M. pneumoniae and to permit molecular
comparisons between wild-type and mutant my-
coplasmas.
Hemadsorption-negative mutants produced
by chemical mutagenesis could be divided into
two different classes (5). One class of mutant,
represented by strain HAl, almost completely
lost the ability to attach to respiratory epithe-
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lium in vitro, yet apparently possessed the same
protein complement as the wild-type parent
strain, as determined by standard one-dimen-
sional sodium dodecyl sulfate (SDS)-polyacryl-
amide gel electrophoresis of mycoplasma total
cell protein. The other class ofnonhemadsorbing
mutant, represented by strain HA2, exhibited a
substantial reduction in its respiratory epithe-
lium attachment ability and also lost the ability
to synthesize at least one high-molecular-weight
protein normally found in the wild-type parent
strain. The availability of these hemadsorption-
negative mutants ofM.pneumoniae has allowed
us to evaluate the specific effect exerted by this
loss of hemadsorption capability on the viru-
lence potential of these mutants both in vitro
and in vivo. In addition, the use of two-dimen-
sional gel electrophoresis has revealed signifi-
cant differences in the protein content of these
hemadsorption-negative mutant strains.
MATERIALS AND METHODS
Organisms and culture media. The virulent,
wild-type M129 strain of M. pneumoniae at broth
passage level 16 (M129-B16) served as the parent
strain. The hemadsorption-negative mutant strains
HAl and HA2 were derived from the M129-B16 strain
by chemical mutagenesis, as described (5). The aviru-
lent M129-B181 strain was derived from M. pneumo-
niae strain M129 by 181 consecutive broth passages
and does not cause microscopic pneumonia in ham-
sters after intranasal inoculation (11). This avirulent
strain of M. pneumoniae is also hemadsorption nega-
tive (11). Cultures of these mycoplasma strains were
grown at 370C in 32-oz. (ca. 0.95-liter) glass prescrip-
tion bottles containing 70 ml of Hayflick medium (9).
Cultures were incubated for 48 to 96 h, until the phenol
red indicator in the growth medium became orange-
yellow in color, approximately pH 6.6. Colony-forming
units (CFU) of these strains were quantitated by plat-
ing serial dilutions of these organisms on Hayflick
medium solidified with 1% (wt/vol) Noble agar (Difco)
and lacking both glucose and phenol red. The hem-
adsorption test (5) was routinely performed on colo-
nies derived from all cultures used in these experi-
ments, to confirm their identity and purity.
Two-dimensional gel electrophoresis. Isoelec-
tric focusing (IEF) SDS-polyacrylamide gel electro-
phoresis and non-equilibrium pH gradient (NEPHGE)
SDS-polyacrylamide gel electrophoresis of myco-
plasma total cell proteins were performed as previ-
ously described (6). Each mycoplasma strain was an-
alyzed in four different IEF- and NEPHGE-SDS gel
electrophoresis experiments. Only those mutant pro-
teins whose presence, quantity, or position in the gel
were consistently altered relative to the proteins of
the virulent parent strain were considered to represent
true protein differences among these strains.
Studies ofmycoplasma attachment to tracheal
rings. Quantitation ofmycoplasma adherence to ham-
ster tracheal rings in vitro was accomplished by the
use of M. pneumoniae radiolabeled with [methyl-
3H]thymidine, as reported previously (9, 15). Deter-
mination of the effect of neuraminidase treatment of
tracheal rings on the adherence of mycoplasmas re-
quired pretreatment of rings with neuraminidase or
buffer. Tracheal rings were placed in microtiter wells
containing 50 pl of pH 7.2 phosphate-buffered saline
or 50 pl of phosphate-buffered saline containing 0.5 U
of neuraminidase (type VIII; Sigma Chemical Co., St.
Louis, Mo.) and were incubated at 37°C for 30 min.
The rings were then rinsed twice in phosphate-
buffered saline and immeaiately used in the standard
mycoplasma attachment assay (15).
Measurement of RNA synthesis in myco-
plasma-infected tracheal rings. Synthesis of ribo-
nucleic acid (RNA) in infected hamster tracheal rings
was quantitated as described previously (7,8), utilizing
[3H]orotic acid (International Chemical and Nuclear
Corp., Irvine, Calif.) as the radiolabeled precursor for
RNA synthesis. Hamster tracheal rings were exposed
to wild-type and mutant strains of M. pneumoniae by
incubating rings with 106 to 107 CFU of mycoplasmas
suspended in 50 il of Hayflick medium containing 10%
fetal calf serum in place of horse serum, to avoid horse
serum toxicity effects on tracheal ring epithelium. This
infection step was performed in an air incubator at
35°C for 5 h. At the end of the infection period, rings
were transferred (without washing or blotting) to fresh
Hayflick medium with 10% fetal calf serum and incu-
bated in a 5% C02 atmosphere at 35°C. This medium
was changed daily to avoid excess growth of myco-
plasmas, which multiplied freely in the growth me-
dium. In addition, the rings were rinsed once in phos-
phate-buffered saline during the daily medium change
to remove loosely associated mycoplasmas. Duplicate
pairs of rings infected with each mycoplasma strain
were harvested at 24- to 48-h intervals for determina-
tion of their RNA synthesis capability.
Infection of hamsters with mycoplasmas. My-
coplasmas used for virulence studies were grown in
Hayflick medium under standard conditions and then
harvested by scraping the glass-attached organisms
into fresh Hayflick medium. Cells of the avirulent
M129-B181 strain, which does not adhere to glass,
were harvested by centrifugation (12,000 x g for 20
min) and then resuspended in fresh medium. Young
adult male Syrian golden hamsters were anaesthetized
by intraperitoneal injection of sodium pentobarbital
and laid in a supine position. A 100-ld volume of
mycoplasma inoculum was then instilled into the an-
terior nares of these animals by sequential addition of
10- to 20-pl portions of the inoculum. The animals
remained in the supine position until they regained
consciousness and then were returned to their cages.
Quantitation of mycoplasma CFU in the lungs of
the infected animals and evaluation of the occurrence
and severity of microscopic pneumonia in these ani-
mals were accomplished by previously published
methods (1, 4). Preliminary experiments established
that the lower limit of detectability of M. pneumoniae
in hamster lung tissue is 103 CFU/g of tissue; at least
a 10-fold dilution of 10% (wt/vol) lung tissue suspen-
sions before plating is made necessary by the presence
in these tissues of substances inhibiting colony growth
of M. pneumoniae (10). Virulence of these myco-
plasma strains was defined as the ability to produce
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significant microscopic pneumonia consisting of pen-
bronchial round-cell infiltration with or without in-
tralumenal polymorphonuclear exudation (1, 4). The
scoring of pneumonia was performed using coded his-
tological lung sections, and the degree of microscopic
pneumonia was rated on a scale of 0 (no evidence of
pneumonia) to 9 (severe pneumonia).
Statistical method. A two-factor analysis of var-
iance was performed on the data involved in Fig. 5.
Significant interaction between strain and time was
found (P < 0.01). Therefore, Newman-Keuls multiple
pairwise comparisons were performed to assess the
differences among strains at each time period. A three-
factor analysis of variance was performed on the data
involved in Fig. 1 and 4. In the presence of interaction,
differences between strains were assessed by the New-
man-Keuls procedure. All Newman-Keuls compari-
sons were performed at the alpha - 0.05 significance
level (17).
RESULTS
General characteristics of hemadsorp-
tion-negative mutant strains HAl and
HA2. Mutant strains HAl and HA2 exhibited
generation times in Hayflick medium similar to
that of the virulent wild-type parent strain
M129-B16 (ca. 7 h; data not shown). Again like
the parent strain, both of these hemadsorption-
negative mutant strains grew primarily as glass-
attached celis in liquid culture, forming a visible
film on the glass surface. Therefore, the genetic
alteration(s) in these mutant mycoplasmas
which resulted in a loss of hemadsorption capa-
bility did not grossly affect the ability of these
mutants to grow and adhere to glass surfaces.
Figure 1 shows that these two hemadsorption-
negative mutants differed from both each other
and the virulent wild-type parent strain in their
respective abilities to attach to tracheal ring
respiratory epithelium. Statistical analysis of
these data showed that these three different
mycoplasma strains all exhibited tracheal ring
attachment frequencies which were significantly
different from one another. Furthermore, the
two mutant strains also differed in their respec-
tive abilities to attach to neuraminidase-treated
hamster tracheal rings. Neuraminidase pretreat-
ment oftracheal rings, which drastically reduced
the frequency of attachment of the wild-type
parent strain, did not affect the relatively low
attachment frequency exhibited by mutant
strain HAl. In contrast, this enzymatic treat-
ment of tracheal rings caused statistically signif-
icant reductions in the attachment frequencies
of both mutant strain HA2 and the wild-type
parent strain.
Two-dimensional gel electrophoresis of
proteins from mutant strains HAl and
HA2. One-dimensional SDS-polyacrylamide gel


























FIG. 1. Effect of neUraminidase pretreatment of
hamster tracheal rings on mycoplasma attachment.
Tracheal ring attachment ofmycoplasmas was mon-
itored by the use of M. pneumoniae labeled with
[methyl-3Hlthymidine (9,15). Equivalent numbers of
CFU (107) of each mycoplasma strain were used in
these experiments. CFU were determined by plating
serial dilutions of radiolabeled mycoplasmas on so-
lidified Hayflick medium (4, 11). These data represent
the mean from two separate experiments in which
three tracheal rings were used for each mycoplasma
strain and ring treatment; the standard deviation is
indicated accordingly. A three-factor analysis ofvar-
iance wasperformed on the actual experimental data,
and in the presence of interaction, differences be-
hween strains were assessed by using the Newman.
Keuls comparisons procedure at the alpha = 0.05
significance level.
strain HA2 lacked a high-molecular-weight pro-
tein possessed by both the virulent wild-type
parent strain and mutant strain HAl (5). Having
recently demonstrated that two-dimensional gel
electrophoretic analysis ofmycoplasma proteins
is a highly sensitive method for detecting minor
protein differences between mycoplasxna strains
(6), we utilized this technique to further char-
acterize total cell proteins from the hemadsorp-
tion-negative mutant strains HAL and HA2.
IEF-SDS gel electrophoretic analysis showed
that mutant strain HA2 exhibited a protein spot
pattern apparently identical to that of the viru-
lent wild-type parent strain M129-B16, and in-
cluded the virulent strain-specific protein A (6;
Fig. 2b). In contrast, the IEF-SDS gels ofmutant
strain HAl differed from those of both the wild-














FIG. 2. IEF-SDS gel electrophoretic analysis ofproteins from hemadsorption-negative mutant strains of
M. pneumoniae. In accordance with standard convention (13), the basic end of the two-dimensional gel is on
the left, the acidic end is on the right, and proteins of decreasing molecular weight run from the top to the
bottom ofthe gel. (a) Mutant strain HAl. The absence ofthe virulent strain-specific protein spotA is indicated
by the circle. The protein spot a-HA) is indicated by the appropriate arrow. (b) Mutant strain HA2. The







mio; 9 _ _ -







least two respects. First, mutant strain HA1
lacked the virulent strain-specific proteinA (Fig.
2a). In addition, mutant strain HAl posessed a
protein (protein spot a-HAl) which had under-
gone an apparent change in its isoelectric point
(Fig. 2a) such that it had become more acidic
relative to the corresponding protein (protein
spot a-HA2) in the wild-type parent strain (6)
and in the mutant strain HA2 (Fig. 2b).
NEPHGE-SDS gel electrophoretic analysis,
which permits resolution of proteins with more
basic isoelectric points (14), also showed that
the protein spot pattern of mutant strain HA2
was apparently identical to that of the virulent
wild-type parent strain, and included the viru-
lent strain-specific protein B and C (6; Fig. 3b).
The use of NEPHGE-SDS gels also identified
new, significant differences between mutant
strain HAl and both the virulent wild-type par-
ent strain and mutant strain HA2, in that mu-
tant strain HAl lacked the virulent-strain spe-
cific proteins B and C (Fig. 3a). In addition, the
apparent shift in the isoelectric point of protein
spot a-HAl is readily evident when the
NEPHGE-SDS gel of this mutant's proteins
(Fig. 3a) is compared to the NEPHGE-SDS gel
of mutant strain HA2 proteins (Fig. 3b).
RNA synthesis in mycoplasma-infected
tracheal rings. Previous studies from this lab-
oratory have established that attachment of vir-
ulentM.pneumoniae to tracheal ring epithelium
disrupts macromolecular synthetic processes in
these tracheal rings, provided the mycoplasmas
remain attached and metabolically active (7, 8).
To determine whether the loss ofhemadsorption
capability has in any way altered the ability of
these mutants to cause alterations in tracheal
ring metabolic processes, RNA synthesis was
monitored in tracheal rings infected with the
virulent wild-type parent strain M129-B16, the
hemadsorption-negative mutant strains, and the
avirulent M129-B181 strain. That mycoplasmas
were present in the tracheal organ culture sys-
tems subsequent to the initial infection phase
and throughout the experimental time period
was confirmed by the quantitation of myco-
plasma CFU in the tracheal organ culture me-
dium during the experiment; between lo' and
107 free-floating CFU ofeach mycoplasma strain
per ml were detected in the media at both 72
and 144 h postinfection (data not shown). There-
fore, the repeated transfer of tracheal rings in-
fected with the mutant strains or the avirulent
strain into fresh medium did not totally remove
these attachment-deficient strains from the or-
gan culture system, where these organisms mul-
tiplied freely. Consequently, the tracheal rings
were constantly exposed to large numbers of
mycoplasmas of all four strains over the course
of the experimental period.
Infection of tracheal rings with the virulent
wild-type parent strain M129-B16 resulted in a
marked and rapid decline in tracheal ring RNA
synthesis ability which was statistically signifi-
cant at 72, 96, and 144 h postinfection (Fig. 4).
In contrast, infection of tracheal rings with the
hemadsorption-negative mutant strains resulted
in a relatively- small decrease in tracheal ring
RNA synthesis ability which became signifi-
cantly different from uninfected control ring val-
ues only at 144 h postinfection. Similarly, the
avirulent strain exerted a small but statistically
signifcant inhibitory effect on tracheal ring
RNA synthesis only at 144 h postinfection.
Virulence of hemadsorption-negative
mutanIts. Animal virulence studies involving
the hemadsorption-negative mutant strains HAl
and HA2 were performed to determine what
effect, if any, the loss of hemadsorption capabil-
ity had on the ability of the mutants to cause
microscopic pneumonia in hamsters. Hamsters
were intranaslly challenged with the virulent
wild-type parent strain M129-B16, the hemad-
sorption-negative mutant strains, and the avir-
ulent strain M129-B181, and the development of
microscopic pneumonia in these animals was
followed with time (Fig. 5). The virulent wild-
type parent strain produced statistically signifi-
cant microscopic pneumonia by 14 days postin-
fection; the lung lesions in animals infected with
this virulent strain were gradually resolved over
the remaining 14-day interval. In contrast, like
the avirulent strain, neither of the hemadsorp-
tion-negative mutant strains caused any signifi-
cant degree of microscopic pneumonia during
the 28-day experimental period.
Comparison ofthese histological data with the
numbers of CFU of the various mycoplasma
strains detected in the lungs of infected animals
showed that only the virulent, wild-type parent
strain persisted at relatively high levels (Table
1). In contrast, CFU of neither hemadsorption-
negative mutant strain could be detected at any
of the sampling times during the course of the
experiment (Table 1). It is noteworthy that
whereas CFU of the avirulent strain were not
demonstrated in the lungs of most infected ani-
mals by 14 days postinfection, avirulent-strain
mycoplasmas were present at barely detectable
levels in a few individual animals throughout
the course of the experiment. Control tests per-
formed with these mycoplsman colonies isolated
from animals infected with the avirulent strain
confirmed that these organisms were M. pneu-
moniae and were also hemadsorption negative.
DISCUSSION
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FIG. 3. NEPHGE-SDSgel electrophoretic analy8is ofproteinsfr-om hemadsorption-negative mutant strains
ofM. pneumoniae. (a) Mutant strain HAl. The absence of the virulent strain-specific protein spots B and C
is indicated by the appropriate circles. Protein spot a-HAl is indicated by the appropriate arrow. (b) Mutant
strain HA2. The virulent strain-specific protein spots B and C, and spot a-HA2, are indicated by arrows. Note
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FIG. 4. RNA synthesis in tracheal rings infected with wild-type, mutant, and avirulent strains of M.
pneumoniae. The numbers ofmycoplasmas used for infection were: M129-B16, 7.3 x 106 CFU; M129-B181, 1.7
x 107 CFU; HAl, 1.7 x 107 CFU; HA2, 1.6 x 107 CFU. These data represent the mean from three separate
experiments in which a pair of tracheal rings infected with each strain was harvested at each time point for
analysis; the standard deviation is indicated accordingly. A three-factor analysis of variance wasperformed
on the actual experimental data, and in thepresence ofinteraction, differences between strains were assessed













FIG. 5. Virulence ofwild-type, mutant, and avirulent strains ofM. pneumoniae in hamsters. Hamsters were
infected intranasally with mycoplasmas suspended in 100 id ofHayflick broth. The inocula employed in this
experiment are listed in Table 1. Each column represents the mean lung lesion score from either two or three
individual aninals; the standard deviation is indicated accordingly. A two-factor analysis of variance was
performed on the actual experimental data to assess the effects of mycoplasma strain and time. Significant
interaction between strain and time was found to be present (P < 0.01). Therefore, Newman-Keuls multiple
pairwise comparisons wereperformed to assess the differences among strains at each timeperiod. These tests
were performed at the alpha = 0.05 significance level.
niae to form colonies which adsorb erythrocytes ity of this respiratory tract pathogen to produce
is a well-known characteristic of this organism, experimental pneumonic disease has not been
although the functional and/or structural rela- previously investigated. The recent isolation of
tionship of this hemadsorption process to both mutants ofM. pneumoniae specifically deficient
























TABLE 1. Quantitation of viable mycoplasmas in hamster lungs after intranasal challenge
Strain anInoculum per CFU/g of lung tissuea at day postinfection:Strain animal(CFU)7142
Wild-type M129-B16 3.0 x 106 3.0 x 105 2.6 x 106 7.5 x iO 6.9 x 10i
6.1 x 105 9.6 x iO5 1.0 x l0o 9.0 x la,
4.5 x i05
HAl 4.2 x 106 ND ND ND ND
ND ND ND ND
ND
HA2 2.0 x 106 ND ND ND ND
ND ND ND ND
ND
M129-B181 2.3 x 106 1.8 x 104 ND 1.0 x l03 1.0 x 103
1.2 x 104 ND ND ND
1.2 x 10'
a Each number represents a single animal. ND, Not detectable, or less than 103 CFU/g of lung tissue.
correlate alterations in the physiology and viru-
lence of this organism with the loss of hemad-
sorption capability.
The hemadsorption-negative mutant strains
HAl and HA2 have been shown to differ mark-
edly in their relative abilities to attach to respi-
ratory epithelium (5; Fig. 1). Similarly, neura-
minidase pretreatment of the tracheal rings em-
ployed in the attachment assay had significantly
different effects on the adherence frequencies of
these two mutants (Fig. 1). Mutant strain HAl
is incapable of hemadsorption and exhibits a
very limited ability to attach to respiratory epi-
thelium. Consequently, neuraminidase pretreat-
ment of tracheal rings does not alter the very
low attachment frequency exhibited by this par-
ticular hemadsorption-negative mutant. In con-
trast, mutant strain HA2 still remains capable of
a significant sialic acid-mediated attachment to
respiratory epithelium in vitro, while completely
losing its hemadsorption ability. Therefore,
hemadsorption is not necessarily synonymous
with respiratory epithelium attachment ability.
Furthermore, these data suggest receptor simi-
larities and differences among these eucaryotic
cells and provide evidence for distinct mecha-
nisms of interaction between the mycoplasma
ligand(s) and the host cell surface.
The use of two-dimensional gel electrophore-
sis has established that these two mutant strains
are distinct from one another in several respects.
The mutant strain HAl differs from mutant
strain HA2 and the wild-type parent strain in its
lack of the virulent strain-specific proteins A, B,
and C and in its possession of a protein (a-HAl)
with an altered isoelectric point (Fig. 2 and 3).
With the exception of this latter protein, the
protein profile of mutant strain HAl on IEF-
SDS and NEPHGE-SDS gels is apparently
identical to that of the avirulent M129-B181
strain, which also fails to hemabsorb (6). In
contrast, the two-dimensional gel patterns of
total cell proteins from mutant strain HA2 are
apparently identical to that of the wild-type
parent strain. The high-molecular-weight pro-
tein which distinguishes the wild-type parent
strain from mutant strain HA2 in one-dimen-
sional SDS-polyacrylamide gels (5) was not re-
solved in two-dimensional gels of wild-type
strain proteins under these experimental condi-
tions. Assessment of the possible involvement of
either the latter protein or the virulent strain-
specific proteins in the hemadsorption process
will require the isolation of hemadsorption-pos-
itive revertants of these nonhemadsorbing mu-
tants and subsequent one- and two-dimensional
gel electrophoretic analyses of the total cell pro-
teins of these revertants.
The loss of hemadsorption capability was
shown to exert a considerable effect on the vir-
ulence of these mutant mycoplasmas for both in
vitro and in vivo systems. In contrast to the
virulent wild-type parent strain, both hemad-
sorption-negative mutants exert only relatively
small inhibitory effects on tracheal ring RNA
synthesis in vitro (Fig. 4). These data indicate
that mutant strain HA2, despite its respiratory
epithelium attachment capability, is unable to
readily disrupt macromolecular biosynthetic
processes in respiratory epithelium. The similar
results obtained with these mutants and the
avirulent strain in this assay system suggested
that this low-level inhibition of tracheal ring
RNA synthesis may be independent of the at-
tachment ability of these mycoplasma strains
and may be related to other effector molecules,
such as mycoplasma-derived metabolic products
accumulating in the epithelial cells of the tra-
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cheal ring.
The hemadsorption-negative mutants were
also shown to be incapable of causing significant
microscopic pneumonia in the hamster model
system (Fig. 5). That these mutants cannot pro-
duce pneumonic disease in hamsters is undoubt-
edly due to the apparent inability of these non-
hemadsorbing mutants to survive or replicate in
vivo (Table 1). The importance of adherence in
the pathogenesis of M. pneumoniae pneumonia
makes the lack of virulence of mutant strain
HAl not surprsing, since this mutant possesses
very little respiratory epithelium attachment
ability. The inability of mutant strain HA2 to
produce microscopic pneumonia in hamsters is
more difficult to reconcile with the apparent in
vitro attachment ability exhibited by this mu-
tant. However, the fact that mutant strain HA2
also cannot inhibit tracheal ring RNA synthesis
more readily than the attachment-deficient
strains HAl and M129-B181 suggests that the
mutation which altered the hemadsorption abil-
ity of mutant strain HA2 also simultaneously
affected both its virulence for tracheal rings in
vitro and its ability to survive, reproduce, and
cause microscopic pneumonia in hamsters. This
explanation and the alternative possibility, that
an undetected secondary mutation in this strain
is responsible for its lack of virulence in these
experimental systems, can only be evaluated by
the isolation and study of a hemadsorption-pos-
itive revertant of mutant strain HA2.
The inability ofthe attachment-deficient avir-
ulent strain M129-B181 to cause pneumonic dis-
ease in hamsters reaffinms the importance of
epithelial cell adherence in the production of
experimental disease by M. pneumoniae in this
model system. Similarly, this avirulent strain
apparently could survive only at barely detect-
able levels in hamster lungs, again indicating the
critical relationship between mycoplasma at-
tachment and the survival and extensive growth
of this organism in the hamster lung. That the
avirulent strain could apparently survive better
in vivo than either of the hemadsorption-nega-
tive mutants may be unrelated to attachment
factors and might involve alteration of antiphag-
ocytic mechanisms or metabolic properties of
these mutants by the same genetic event(s)
which eliminated their hemadsorption ability.
In conclusion, the use ofthese hemadsorption-
negative mutants has shown that the loss of
hemadsorption capability can be correlated with
several significant changes in the biochemistry
and virulence of this organism. Indeed, the ap-
parent lack of pathogenicity of these hemad-
sorption-negative mutants in the hamster model
system warrants experimental investigation of
the possibility of employing these mutants as
vaccinogens. Precise determination of the struc-
tural and functional relationship of the hemad-
sorption process to the survival, growth, and
virulence of M. pneumoniae in vivo must nec-
essarily await the isolation of hemadsorption-
positive revertants of these mutant strains. Ex-
periments designed to isolate these revertants
are currently in progress.
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